(Q81080609)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15573022%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

CRHR1 antagonists as novel treatment strategies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15573022%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

F Holsboer

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15573022%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 July 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15573022%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

number of pages

5

1 reference

inferred from page(s)

published in

C N S Spectrums

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15573022%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15573022%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15573022%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

590-594

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15573022%20AND%20SRC:MED&resulttype=core&format=json

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

The anxiolytic effect of the CRH(1) receptor antagonist R121919 depends on innate emotionality in rats.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Selective corticotropin-releasing factor type 1 receptor antagonist blocks conditioned fear-induced release of noradrenaline in the hypothalamic paraventricular nucleus of rats.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Non-peptidic corticotropin-releasing hormone receptor type 1 antagonist reverses restraint stress-induced shortening of sodium pentobarbital-induced sleeping time of rats: evidence that an increase in arousal induced by stress is mediated through CR

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Corticotropin-releasing hormone receptor antagonists: framework design and synthesis guided by ligand conformational studies

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Suppression of conditioned fear by administration of CRF receptor antagonist CP-154,526.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Behavioural profiles of two Wistar rat lines selectively bred for high or low anxiety-related behaviour.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Synthetic Competitive Antagonists of Corticotropin-Releasing Factor: Effect on ACTH Secretion in the Rat

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Corticotropin-releasing hormone receptor (type I) antisense targeting reduces anxiety.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

The role of corticotropin releasing factor in depressive illness: a critical review.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Psychiatric implications of basic and clinical studies with corticotropin-releasing factor

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Blunted Corticotropin and Normal Cortisol Response to Human Corticotropin-Releasing Factor in Depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900002133

7 January 2021

10.1017/S1092852900002133

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15573022%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference